Insights on Early Stage RCC Detection & Emerging Management Strategies
Insights on Early Stage RCC Detection & Emerging Management Strategies
Recording from June 22, 2023
Speakers: Aly-Khan Lalani & Simon Tanguay
Objectives:
- Recognize early RCC disease stage symptoms and underlying risk factors associated with recurrence rates
- Assess emergent adjuvant RCC clinical trial data and their impact on current clinical practice
- Identify key patient factors important for the consideration of adjuvant therapy in early stage RCC
ACCREDITATION
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.
This program has received financial support from AstraZeneca / Merck in the form of an educational grant.